Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study

Cristina Rigamonti; Micol Giulia Cittone; Carla De Benedittis; Eleonora Rizzi; Giuseppe Francesco Casciaro; Mattia Bellan; Pier Paolo Sainaghi; Mario Pirisi

doi:10.1016/j.cgh.2020.05.047

Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study

Clin Gastroenterol Hepatol. 2020 Sep;18(10):2369-2371.e1. doi: 10.1016/j.cgh.2020.05.047. Epub 2020 May 30.

Authors

Cristina Rigamonti¹, Micol Giulia Cittone², Carla De Benedittis², Eleonora Rizzi², Giuseppe Francesco Casciaro², Mattia Bellan², Pier Paolo Sainaghi², Mario Pirisi²

Affiliations

¹ Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy. Electronic address: cristina.rigamonti@med.uniupo.it.
² Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus responsible for a variety of clinical manifestations that, besides the lungs, can involve several other organs, leading to both mild and severe complications.^1-3.

MeSH terms

Adult
Autoimmune Diseases / diagnosis*
Autoimmune Diseases / immunology
Betacoronavirus*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / diagnosis*
Coronavirus Infections / epidemiology
Female
Humans
Italy / epidemiology
Liver Diseases / diagnosis*
Liver Diseases / immunology
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / epidemiology
SARS-CoV-2
Telemedicine / methods*